Related Experiment Videos

Immune-reactivity of recombinant isoforms of the major house dust mite allergen Der p 2

G A Hakkaart1, M D Chapman, R C Aalberse

  • 1Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, University of Amsterdam.

Abstract

Insights

Recombinant Der p 2 isoforms were created to understand why some antibodies didn't react. A change at position 114 restored antibody binding, suggesting isoforms affect antibody recognition in Der p 2 allergen studies.

Area of Science:

  • Molecular biology
  • Immunology
  • Allergen research

Background:

  • Recombinant Der p 2 produced in yeast showed limited reactivity with monoclonal antibodies specific to natural Der p 2.
  • This discrepancy prompted an investigation into potential causes, such as the existence of Der p 2 isoforms.

Purpose of the Study:

  • To investigate if the lack of reactivity of certain monoclonal antibodies with recombinant Der p 2 is due to different isoforms.
  • To characterize the impact of specific amino acid substitutions on Der p 2 isoform recognition.

Main Methods:

  • Site-directed mutagenesis was used to create three recombinant Der p 2 isoforms.
  • Reactivity of these isoforms with monoclonal antibodies and human IgE was assessed using Radioallergosorbent Test (RAST) and RAST-inhibition assays.

Main Results:

  • Replacing aspartic acid with asparagine at position 114 restored reactivity with all five previously non-reactive monoclonal antibodies.
  • Substitutions at positions 26 and 47 did not affect antibody binding.
  • Human IgE binding was not significantly altered by the amino acid change at position 114.

Conclusions:

  • Monoclonal antibodies can distinguish between Der p 2 isoforms, enabling studies on natural isoform occurrence.
  • For reliable allergen measurement assays, monoclonal antibodies that do not discriminate between isoforms should be selected.

Related Concept Videos